Veterinary Biomarker Monitoring: Kidney, Cardiac, and Beyond

Infectious-disease testing answers “is the pathogen present?” — but a large share of veterinary illness is non-infectious, driven by organ dysfunction, inflammation, and metabolic disease. For these conditions, quantitative biomarkers are the diagnostic key. This guide covers the major biomarkers measured in modern veterinary practice and how point-of-care testing has transformed their use.

Why Biomarkers Matter

A biomarker is any measurable substance whose level reflects a biological or disease state. Unlike clinical signs, which appear late, biomarkers often change early in disease — sometimes before the animal shows any outward symptoms. Quantitative, serial biomarker measurement therefore enables:

• Earlier diagnosis — detecting disease in its reversible phase.
• Objective staging — quantifying severity.
• Treatment monitoring — tracking whether therapy is working.
• Prognostication — predicting outcomes.

Renal Biomarkers

SDMA (Symmetric Dimethylarginine)

SDMA is a by-product of protein metabolism excreted almost entirely by the kidneys. Its defining advantage is that it rises earlier than creatinine — when as little as 25–40% of kidney function is lost, versus 60–70% for creatinine.

• Detects chronic kidney disease (CKD) earlier.
• Independent of muscle mass — unlike creatinine, not confounded by cachexia or muscle wasting.
• Supports IRIS staging of CKD.

For a full treatment, see Early Detection of Chronic Kidney Disease: The Role of SDMA and What Is SDMA in Cats?.

Cystatin C

Cystatin C is another early renal marker, produced at a constant rate and filtered by the glomerulus. Like SDMA, it rises before creatinine and is less influenced by muscle mass. Cystatin C is available for both dogs and cats.

Related products: Canine Cystatin C Test · Feline Cystatin C Test · SDMA CKD Kit

Cardiac Biomarkers

NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide)

When the heart muscle is stretched or stressed — as in congestive heart failure or significant cardiac disease — it releases B-type natriuretic peptide. The stable N-terminal fragment, NT-proBNP, is measurable in blood.

• Screens for occult cardiac disease before clinical signs appear.
• Distinguishes cardiac from respiratory causes of dyspnoea and cough.
• Monitors heart-failure therapy.

NT-proBNP is especially valuable in breeds predisposed to heart disease (e.g., Cavalier King Charles Spaniels with mitral valve disease) and in cats, where heart disease is often silent.

Related products: Canine NT-proBNP Test · Feline NT-proBNP Test

Pancreatic Biomarkers

Pancreatic Lipase (fPL / cPL)

Pancreatic lipase is specific to the pancreas and rises during pancreatitis. Species-specific assays (feline pancreatic lipase, fPL; canine pancreatic lipase, cPL) provide much higher diagnostic accuracy than older amylase/lipase measurements.

• Diagnoses pancreatitis with high sensitivity and specificity.
• Monitors disease severity and recovery.

Related products: Canine Pancreatic Lipase Test · Feline Pancreatic Lipase Test

Inflammatory Biomarkers

C-Reactive Protein (CRP)

CRP is a major acute-phase protein in dogs. It rises rapidly during inflammation and infection and falls just as rapidly with successful treatment.

• Detects and quantifies systemic inflammation.
• Monitors response to therapy — a falling CRP confirms treatment is working.
• Distinguishes inflammatory from non-inflammatory disease.

Serum Amyloid A (SAA)

SAA is the major acute-phase protein in cats (and also rises in dogs). It increases dramatically within hours of an inflammatory stimulus.

• Early, sensitive marker of inflammation in cats.
• Monitors treatment response.

Related products: Canine CRP Test · Feline SAA Test

Thyroid Biomarkers

Total Thyroxine (T4) and TSH

Thyroid hormones regulate metabolism. Hypothyroidism (low T4, high TSH) is common in dogs; hyperthyroidism (high T4) is common in older cats.

• T4 — primary thyroid hormone measurement.
• TSH — pituitary hormone; elevated in canine hypothyroidism.
• Combined T4 + TSH — improves diagnostic accuracy for hypothyroidism.

See What Is a Feline Thyroid Test?.

Related products: Canine T4 Test · Canine TSH Test · Feline T4 Test

Reproductive Biomarkers

Progesterone

Progesterone measurement is essential for canine breeding management — determining the optimal mating or insemination time.

• Tracks the oestrous cycle.
• Times ovulation for optimal breeding or artificial insemination.
• Predicts whelping date.

Relaxin

Relaxin is produced by the placenta and is a reliable pregnancy marker in dogs.

• Confirms pregnancy from around day 21–28 post-ovulation.
• Distinguishes true pregnancy from pseudopregnancy.

See What Is a Canine Pregnancy Test?.

Related products: Canine Progesterone Test · Canine Relaxin Test

Other Biomarkers

Cortisol

Cortisol measurement supports diagnosis of hyperadrenocorticism (Cushing’s) and hypoadrenocorticism (Addison’s).

Related product: Canine Cortisol Test

The Power of Serial Testing

A single biomarker value is informative; a trend is transformative. Serial measurement reveals whether disease is progressing or responding to treatment:

• A rising SDMA signals advancing kidney disease; a stabilising SDMA confirms therapy is working.
• A falling CRP confirms infection is resolving.
• A rising progesterone pinpoints the exact day to breed.

Point-of-care quantitative testing makes this serial monitoring practical — results in minutes, at the cage-side, without the delay and cost of repeated laboratory submissions.

Conclusion

Quantitative biomarkers have moved veterinary medicine from reactive, sign-based diagnosis to proactive, early detection. By measuring the right biomarker at the right time — and tracking it over time — clinicians can diagnose earlier, treat more effectively, and give owners clearer answers.